Faculty, Staff and Student Publications
Language
English
Publication Date
1-1-2024
Journal
International Journal of Immunopathology and Pharmacology
DOI
10.1177/03946320241265265
PMID
38889772
PMCID
PMC11186393
PubMedCentral® Posted Date
6-18-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Introduction: Exceedingly high levels of the chemokine CCL5/RANTES have been found in fatty degenerated osteonecrotic alveolar bone cavities (FDOJ) and aseptic ischemic osteolysis of the jaw (AIOJ) from toothless regions. Because CCL5/RANTES seems to have a prominent role in creating the COVID-19 “cytokine storm”, some researchers have used the monoclonal antibody Leronlimab to block the CCR5 on inflammatory cells.
Objective: Is preexisting FDOJ/AIOJ jaw marrow pathology a “hidden” co-morbidity affecting some COVID-19 infections? To what extent does the chronic CCL5/RANTES expression from preexisting FDOJ/AIOJ areas contribute to the progression of the acute cytokine storm in COVID-19 patients?
Methods: Authors report on reducing the COVID-19 “cytokine storm” by treating infected patients through targeting the chemokine receptor 5 (CCR5) with Leronlimab and interrupting the activation of CCR5 by high CCL5/RANTES signaling, thus dysregulating the inflammatory phase of the viremia. Surgical removal of FDOJ/AIOJ lesions with high CCL5/RANTES from patients with inflammatory diseases may be classified as a co-morbid disease.
Results: Both multiplex analysis of 249 FDOJ/AIOJ bone tissue samples as well as serum levels of CCL5/RANTES displayed exceedingly high levels in both specimens.
Discussion: By the results the authors hypothesize that chronic CCL5/RANTES induction from FDOJ/AIOJ areas may sensitize CCR5 throughout the immune system, thus, enabling it to amplify its response when confronted with the virus. As conventional intraoral radiography does little to assess the quality of the alveolar bone, ultrasonography units are available to help dentists locate the FDOJ/AIOJ lesions in an office setting.
Conclusion: The authors propose a new approach to containment of the COVID-19 cytokine storm by a prophylactic focus for future viral-related pandemics, which may be early surgical clean-up of CCL5/RANTES expression sources in the FDOJ/AIOJ areas, thus diminishing a possible pre-sensitization of CCR5. A more complete dental examination includes trans-alveolar ultrasono-graphy (TAU) for hidden FDOJ/AIOJ lesions.
Keywords
Humans, Chemokine CCL5, Comorbidity, Male, Female, Middle Aged, Receptors, CCR5, Aged, Jaw Diseases, SARS-CoV-2, Cytokine Release Syndrome, Antibodies, Monoclonal, Humanized, Adult, COVID-19, CCR5, monoclonal antibody, cytokine-storm, DAMPS, PAMPS, AIOJ, FDOJ, enoral ultrasonography
Published Open-Access
yes
Recommended Citation
, "Is Preexisting Inflamed Jaw Marrow a “Hidden” Co-morbidity Affecting Outcomes of COVID-19 Infections? – Clinical Comparative Study" (2024). Faculty, Staff and Student Publications. 53.
https://digitalcommons.library.tmc.edu/uthdb_docs/53